MentionFox
Home › funding signals › Phoreus Biotechnology, Inc.
Company · SEC filings

Phoreus Biotechnology, Inc. funding history

Phoreus Biotechnology, Inc. has 2 Form D filings on record, from 2026-03-13. Together its new offerings report $421K sold.

Pitching, partnering or investing alongside them? See who really runs and owns Phoreus Biotechnology, Inc.

Free to see. No signup.

Is this your company?

Funding historyFounders and team

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Phoreus Biotechnology, Inc.: Raised $421K, Form D filed 2026-03-13
Share on LinkedIn Share on X Download image

Is Phoreus Biotechnology, Inc. a real, registered company?

Phoreus Biotechnology, Inc. is a registered filer with the SEC (CIK 1748964) and has filed since 2026-03-13. 2 filings are on record, the latest on 2026-03-13.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Phoreus Biotechnology, Inc.?

Phoreus Biotechnology, Inc.'s filings name Bill Ashley, David Schaefer, Douglas Shane and 4 more as its officers, directors or promoters.

How much has Phoreus Biotechnology, Inc. raised?

Its new offerings report $421K sold across 1 offering, as its own filings state.

Run the free check on Phoreus Biotechnology, Inc. →

Based
OLATHE, KANSAS
Industry group
Biotechnology
Filings
2
Raised (new offerings)
$421K

Every filing

FiledTypeAmount soldTotal offeringRecords
2026-03-13New offering
first sale 2025-11-05
$421K—details · SEC filing
2026-03-13Amendment
first sale 2020-07-20
$4.43M—SEC filing

Keep reading

More on Phoreus Biotechnology, Inc. and the records around it.

Phoreus Biotechnology, Inc. elsewhere on the record

What do you want to do with Phoreus Biotechnology, Inc.?

Want the whole picture on Phoreus Biotechnology, Inc.?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Phoreus Biotechnology, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Phoreus Biotechnology, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from Phoreus Biotechnology, Inc.'s own filings with the SEC. The people those filings name are on the team page.

Filings & events

Fundraising filings

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Phoreus Biotechnology, Inc.. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/company/phoreus-biotechnology-inc
Last updated 2026-11-01
Primary record: SEC filing 1 · SEC filing 2
How much has Phoreus Biotechnology, Inc. raised? $421K in 2 SEC filings. MentionFox, 2026-11-01. https://mentionfox.com/company/phoreus-biotechnology-inc